SmithKline Beckman Corp.: The Philadelphia pharmaceutical company...
- Share via
SmithKline Beckman Corp.: The Philadelphia pharmaceutical company said second-quarter earnings were $164.8 million, up 28% from a year ago. Sales were up 10% to $1.26 billion. The firm said each of its units contributed to the rise in sales and earnings.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
